These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11790397)

  • 1. Disturbance of the nigro-amygdaloid connections in dementia with Lewy bodies.
    Jellinger KA
    J Neurol Sci; 2002 Jan; 193(2):157-8. PubMed ID: 11790397
    [No Abstract]   [Full Text] [Related]  

  • 2. The nigro-striatal and nigro-amygdaloid pathways undergo different degeneration processes in brains of dementia with Lewy bodies.
    Iseki E; Marui W; Yamamoto R; Togo T; Katsuse O; Kato M; Iwatsubo T; Kosaka K; Arai H
    Neurosci Lett; 2005 May 20-27; 380(1-2):161-5. PubMed ID: 15854770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A neuropathological study of the disturbance of the nigro-amygdaloid connections in brains from patients with dementia with Lewy bodies.
    Iseki E; Kato M; Marui W; Uéda K; Kosaka K
    J Neurol Sci; 2001 Apr; 185(2):129-34. PubMed ID: 11311294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lewy bodies in patients presenting clinically with Alzheimer disease.
    Jellinger KA; Seppi K; Wenning GK
    J Alzheimers Dis; 2002 Aug; 4(4):327-8. PubMed ID: 12446935
    [No Abstract]   [Full Text] [Related]  

  • 5. A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death.
    Greffard S; Verny M; Bonnet AM; Seilhean D; Hauw JJ; Duyckaerts C
    Neurobiol Aging; 2010 Jan; 31(1):99-103. PubMed ID: 18457903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TorsinA accumulation in Lewy bodies in sporadic Parkinson's disease.
    Shashidharan P; Good PF; Hsu A; Perl DP; Brin MF; Olanow CW
    Brain Res; 2000 Sep; 877(2):379-81. PubMed ID: 10986355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraneuronal Lewy body inclusions in Parkinson and diffuse Lewy body disease.
    Bogdanovic N
    J Cell Mol Med; 2001; 5(3):318-9. PubMed ID: 12067491
    [No Abstract]   [Full Text] [Related]  

  • 8. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substantia nigra Marinesco bodies are associated with decreased striatal expression of dopaminergic markers.
    Beach TG; Walker DG; Sue LI; Newell A; Adler CC; Joyce JN
    J Neuropathol Exp Neurol; 2004 Apr; 63(4):329-37. PubMed ID: 15099023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia.
    Trojanowski JQ; Lee VM
    Arch Neurol; 1998 Feb; 55(2):151-2. PubMed ID: 9482355
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterisation of isolated alpha-synuclein filaments from substantia nigra of Parkinson's disease brain.
    Crowther RA; Daniel SE; Goedert M
    Neurosci Lett; 2000 Oct; 292(2):128-30. PubMed ID: 10998565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of Lewy pathology in the visual pathway of brains of dementia with Lewy bodies.
    Yamamoto R; Iseki E; Murayama N; Minegishi M; Marui W; Togo T; Katsuse O; Kato M; Iwatsubo T; Kosaka K; Arai H
    J Neurol Sci; 2006 Jul; 246(1-2):95-101. PubMed ID: 16624323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential diagnosis of parkinsonism.
    Facca AG; Koller WC
    Adv Neurol; 2003; 91():383-96. PubMed ID: 12442697
    [No Abstract]   [Full Text] [Related]  

  • 14. Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies.
    Beyer MK; Larsen JP; Aarsland D
    Neurology; 2007 Aug; 69(8):747-54. PubMed ID: 17709706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease.
    Ferrer I; Perez E; Dalfó E; Barrachina M
    Neurosci Lett; 2007 Mar; 415(3):205-9. PubMed ID: 17284347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cycles of aberrant synaptic sprouting and neurodegeneration in Alzheimer's and dementia with Lewy bodies.
    Hashimoto M; Masliah E
    Neurochem Res; 2003 Nov; 28(11):1743-56. PubMed ID: 14584828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases.
    Pletnikova O; West N; Lee MK; Rudow GL; Skolasky RL; Dawson TM; Marsh L; Troncoso JC
    Neurobiol Aging; 2005; 26(8):1183-92. PubMed ID: 15917102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nigral and extranigral pathology in Parkinson's disease.
    Braak H; Braak E; Yilmazer D; Schultz C; de Vos RA; Jansen EN
    J Neural Transm Suppl; 1995; 46():15-31. PubMed ID: 8821039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies.
    Barrachina M; Castaño E; Dalfó E; Maes T; Buesa C; Ferrer I
    Neurobiol Dis; 2006 May; 22(2):265-73. PubMed ID: 16380264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease.
    Parkkinen L; Soininen H; Alafuzoff I
    J Neuropathol Exp Neurol; 2003 Apr; 62(4):363-7. PubMed ID: 12722828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.